Clinical

Dataset Information

0

Radiotherapy in Combination With Sintilimab,GM-CSF and Fruquintinib in Patients With MSS mCRC


ABSTRACT: To evaluate the clinical efficacy and safety of hypofractionation radiotherapy combined with sintilimab,GM-CSF and Fruquintinib in Patients With MSS Metastatic Colorectal Carcinoma (mCRC)

DISEASE(S): Colorectal Neoplasms

PROVIDER: 2710363 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2017-10-09 | GSE104719 | GEO
2017-10-09 | GSE104718 | GEO
2014-11-27 | GSE63662 | GEO
2023-03-29 | PXD041180 |
2020-02-19 | PXD012794 | Pride
2022-11-03 | GSE216704 | GEO
2012-05-20 | E-GEOD-37029 | biostudies-arrayexpress
2014-11-27 | E-GEOD-63662 | biostudies-arrayexpress
2022-11-03 | GSE216701 | GEO
2012-04-13 | GSE27792 | GEO